While transcriptomic signatures corresponding to cytotoxic CD4+ T cells have been identified in patients with melanoma and bladder cancer31,32 and direct tumor recognition by CD4+ T cells has been observed33,34, studies also suggest that only a small subset of melanomas harbor any MHC-II+ cells35. This evidence concerns the gene CD4 and melanoma.